Clearmind Medicine Inc.
CMND · XNASCIK 1892500fmd_1396MC5DXCYGTASBXYKS6DQ61RManufacturing · Pharmaceutical PreparationsTemplate: Standard
Coverage: Nov 01, 2019 to Jan 31, 2026, 18 periods
| Line item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Research and development | 0 | 3 | 2 | 1 | 2 |
| Selling, general and administrative | 2 | 3 | 5 | 4 | – |
| Interest expense | – | – | – | 0 | 0 |
| Income before taxes | (3) | (7) | (9) | (5) | (4) |
| Income tax expense | – | 0 | 0 | 0 | 0 |
| Net income from continuing operations | – | (7) | (9) | (5) | (4) |
| Net income | (3) | (7) | (9) | (5) | (4) |